Itolizumab to save many COVID 19 patients, asserts Biocon Ltd
After India’s drug regulator approved Itolizumab, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory […]
After India’s drug regulator approved Itolizumab, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory […]